isoalantolactone has been researched along with Esophageal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Li, ZH; Liu, ZX; Lü, H; Tian, ZQ; Wen, SW; Xu, YZ; Zhang, YF; Zhu, YG | 1 |
| Fang, M; Hua, P; Liu, T; Lu, Z; Wu, M; Zhang, G; Zhang, Y | 1 |
2 other study(ies) available for isoalantolactone and Esophageal Neoplasms
| Article | Year |
|---|---|
Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; RNA-Binding Proteins; Sesquiterpenes; Signal Transduction; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Esophageal Neoplasms; Humans; Mice, Inbred BALB C; Mice, Nude; Oxidative Stress; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Sesquiterpenes; Signal Transduction; Up-Regulation; Xenograft Model Antitumor Assays | 2018 |